IT1313629B1 - Formulazioni di estramustina fosfato ed albumina per uso parenterale - Google Patents
Formulazioni di estramustina fosfato ed albumina per uso parenteraleInfo
- Publication number
- IT1313629B1 IT1313629B1 ITMI991998A IT1313629B1 IT 1313629 B1 IT1313629 B1 IT 1313629B1 IT MI991998 A ITMI991998 A IT MI991998A IT 1313629 B1 IT1313629 B1 IT 1313629B1
- Authority
- IT
- Italy
- Prior art keywords
- human albumin
- colorectal
- melanoma
- ovarian
- pancreatic
- Prior art date
Links
- 229960004750 estramustine phosphate Drugs 0.000 title abstract 9
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title abstract 9
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 8
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000003174 Brain Neoplasms Diseases 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 title 1
- 241001326189 Gyrodactylus prostae Species 0.000 title 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 title 1
- 210000000481 breast Anatomy 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 210000004072 lung Anatomy 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title 1
- 201000001441 melanoma Diseases 0.000 title 1
- 230000002611 ovarian Effects 0.000 title 1
- 201000002528 pancreatic cancer Diseases 0.000 title 1
- 208000008443 pancreatic carcinoma Diseases 0.000 title 1
- 239000003085 diluting agent Substances 0.000 abstract 2
- 238000011319 anticancer therapy Methods 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008176 lyophilized powder Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI001998 IT1313629B1 (it) | 1999-09-27 | 1999-09-27 | Formulazioni di estramustina fosfato ed albumina per uso parenterale |
| EP00949471A EP1206266A2 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| JP2001514963A JP2003506408A (ja) | 1999-08-09 | 2000-08-03 | エストラムスチンリン酸及びアルブミンの非経口使用のための配合物 |
| CZ2002376A CZ2002376A3 (cs) | 1999-08-09 | 2000-08-03 | Přípravky pro mimostřevní pouľití estramustin-fosfátu a albuminu |
| CNA008114420A CN1511037A (zh) | 1999-08-09 | 2000-08-03 | 非肠道使用的雌莫司汀磷酸盐和白蛋白的制剂 |
| PL00353406A PL353406A1 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| PCT/EP2000/007678 WO2001010446A2 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| BR0013276-4A BR0013276A (pt) | 1999-08-09 | 2000-08-03 | Formulação farmacêutica para uso parenteral que compreende fosfato de estramustina, como ingrediente ativo |
| NZ517632A NZ517632A (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| MXPA02001395A MXPA02001395A (es) | 1999-08-09 | 2000-08-03 | Formulaciones para uso parenteral de estramustinfosfato y albumina. |
| KR1020027001700A KR20020019967A (ko) | 1999-08-09 | 2000-08-03 | 에스트라무스틴 포스페이트 및 알부민의 비경구용 제형 |
| IL14774500A IL147745A0 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| AU62809/00A AU6280900A (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| HU0202645A HUP0202645A3 (en) | 1999-08-09 | 2000-08-03 | Fornulations for parenteral use of estramustine phosphate and albumin |
| SK178-2002A SK1782002A3 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| CA002380312A CA2380312A1 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
| EA200200234A EA200200234A1 (ru) | 1999-08-09 | 2000-08-03 | Препараты для парентерального применения эстрамустин фосфата и альбумина |
| NO20020631A NO20020631L (no) | 1999-08-09 | 2002-02-08 | Formuleringer for parenteral bruk av estramustinfosfat og albumin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI001998 IT1313629B1 (it) | 1999-09-27 | 1999-09-27 | Formulazioni di estramustina fosfato ed albumina per uso parenterale |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI991998A0 ITMI991998A0 (it) | 1999-09-27 |
| ITMI991998A1 ITMI991998A1 (it) | 2001-03-27 |
| IT1313629B1 true IT1313629B1 (it) | 2002-09-09 |
Family
ID=11383661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT1999MI001998 IT1313629B1 (it) | 1999-08-09 | 1999-09-27 | Formulazioni di estramustina fosfato ed albumina per uso parenterale |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1313629B1 (it) |
-
1999
- 1999-09-27 IT IT1999MI001998 patent/IT1313629B1/it active
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI991998A0 (it) | 1999-09-27 |
| ITMI991998A1 (it) | 2001-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU773506B2 (en) | Antitumour synergistic composition | |
| US5728687A (en) | Antitumour compositions containing taxane derivatives | |
| UA70942C2 (uk) | Застосування n-заміщеного індоліл-3-гліоксиламіду як протипухлинного засобу, спосіб лікування пухлинних захворювань та лікарська композиція для лікування пухлинних захворювань | |
| EP1181013A4 (en) | METHOD AND COMPOSITION FOR TREATING CANCER | |
| MY140398A (en) | 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES | |
| CA2412795A1 (en) | Improved liposomal camptothecins and uses thereof | |
| HUP0203238A3 (en) | Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them | |
| HUP0002521A2 (hu) | A paclitaxel ónium sói, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények | |
| AU758191B2 (en) | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate | |
| HU894581D0 (en) | Alkoxy-4(1h)-pyridone derivatives, process for producing these compounds and pharmaceutical preparatives containing them as active substance | |
| KR20040018341A (ko) | 암치료용 약제 조성물 | |
| PT1478355E (pt) | Composições antitumorais contendo derivados de taxano. | |
| PL342614A1 (en) | Anticarcinogenic drugs | |
| EP1545479A4 (en) | EZETIMIB COMPOSITIONS AND METHOD FOR THE TREATMENT OF CHOLESTERIN-ASSOCIATED GOOD AND EVIL TUMORS | |
| WO2003017939A3 (en) | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment | |
| Aapro et al. | Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine | |
| TR199801732T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
| HUP0302296A2 (hu) | Eljárás és készítmény rák kezelésére, apoptosist indukáló kemoterápiás szerek adagolásával | |
| Kerr | 5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment? | |
| Rose et al. | Preclinical antitumor activity of water-soluble paclitaxel derivatives | |
| IT1313629B1 (it) | Formulazioni di estramustina fosfato ed albumina per uso parenterale | |
| BG105216A (en) | Use of camptothecin derivatives , with reduced gastrointestinal toxicity | |
| WO2001007418A3 (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| Greco | Chronic etoposide administration: overview of clinical experience | |
| MY119575A (en) | Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them |